Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Anti-CD73 MAb enhances antitumor activity of anti-PD-1 treatment

May 6, 2015

First preclinical results presented for a novel HER2-targeted ADC

May 4, 2015

Award supports development of entolimod for metastatic breast cancer

April 30, 2015

Ofatumumab plus fludarabine and cyclophosphamide meets endpoint in phase III trial in CLL

April 29, 2015

Double-armed oncolytic adenovirus LOAd-703 controls tumor progression

April 29, 2015

EMA classifies NeoStem's NBS-20 as advanced therapeutic medicinal product

April 28, 2015

EMA committee recommends approval of Opdivo for advanced melanoma

April 27, 2015

MedImmune and Juno Therapeutics partner for immuno-oncology clinical trials

April 27, 2015

Celgene and MedImmune collaborate to develop MEDI-4736 for hematologic malignancies

April 24, 2015

Enrollment open in phase II study of GI-6301 for chordoma

April 24, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...